James Murdoch (pictured) continues to gain wider experience of the business world after being appointed as a non-executive director of pharmaceutical giant GlaxoSmithKline.
The 36-year-old is widely expected to take over leadership of News Corporation, headed by his father Rupert. James was promoted to chairman and CEO for News Corp's Europe and Asia division in December 2007.
He will join GSK's board on 20 May 2009 and receive fees of £75,000 per annum. He also becomes a member of the company's Corporate Responsibility Committee.
"I am delighted to welcome James to the Board of GSK. His experience of global business, marketing and communications will bring a unique and alternative perspective to the Board," said Sir Christopher Gent, chairman of GSK.
"He will also be an excellent addition to the board's Corporate Responsibility Committee, an area where he has shown particular leadership at BSkyB and News Corp."
In addition to his role at GSK, James also serves on the board of Yankee Global Enterprises, the board of trustees of the Harvard Lampoon and the Leadership Council of The Climate Group.
Murdoch family prolongs dynasty with new appointment